These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 8105937

  • 1. Vitamin D therapy in CAPD: what is its role?
    Hutchison AJ, Gokal R.
    Adv Perit Dial; 1993; 9():253-6. PubMed ID: 8105937
    [Abstract] [Full Text] [Related]

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 3. Progress of renal osteodystrophy during continuous ambulatory peritoneal dialysis.
    Buccianti G, Bianchi ML, Valenti G.
    Clin Nephrol; 1984 Dec; 22(6):279-83. PubMed ID: 6525771
    [Abstract] [Full Text] [Related]

  • 4. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate.
    Cho MS, Lee KS, Lee YK, Ma SK, Ko JH, Kim SW, Kim NH, Choi KC.
    Korean J Intern Med; 2002 Jun; 17(2):114-21. PubMed ID: 12164088
    [Abstract] [Full Text] [Related]

  • 5. Low dialysate calcium in continuous ambulatory peritoneal dialysis: a randomized controlled multicenter trial. The Peritoneal Dialysis Multicenter Study Group.
    Weinreich T, Passlick-Deetjen J, Ritz E.
    Am J Kidney Dis; 1995 Mar; 25(3):452-60. PubMed ID: 7872324
    [Abstract] [Full Text] [Related]

  • 6. Control of mineral metabolism in CAPD patients.
    Delmez JA.
    Blood Purif; 1989 Mar; 7(2-3):167-80. PubMed ID: 2663036
    [Abstract] [Full Text] [Related]

  • 7. Spectrum of renal osteodystrophy in children on continuous ambulatory peritoneal dialysis.
    Yalçinkaya F, Ince E, Tümer N, Ensari A, Ozkaya N.
    Pediatr Int; 2000 Feb; 42(1):53-7. PubMed ID: 10703235
    [Abstract] [Full Text] [Related]

  • 8. Pulse oral calcitriol to treat hyperparathyroidism in 43 CAPD patients.
    Juergensen P, Santacroce S, Mooraki A, Cooper K, Finkelstein FO, Kliger AS.
    Adv Perit Dial; 1994 Feb; 10():259-60. PubMed ID: 7999840
    [Abstract] [Full Text] [Related]

  • 9. Calcium kinetic studies in patients on CAPD: improvement of secondary hyperparathyroidism without concomitant improvement of calcium turnover.
    Kurz P, Tsobanelis T, Brunkhorst R, Roth P, Werner E, Schoeppe W, Vlachojannis J.
    Perit Dial Int; 1997 Feb; 17(1):59-65. PubMed ID: 9068024
    [Abstract] [Full Text] [Related]

  • 10. Differences in calcium kinetic pattern between CAPD and HD patients.
    Kurz P, Tsobanelis T, Roth P, Werner E, Ewald U, Grützmacher P, Schoeppe W, Vlachojannis J.
    Clin Nephrol; 1995 Oct; 44(4):255-61. PubMed ID: 8575126
    [Abstract] [Full Text] [Related]

  • 11. [Renal osteodystrophy and growth in children undergoing CAPD].
    Ito T, Horiike S, Iitaka K.
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):779-90. PubMed ID: 1770638
    [Abstract] [Full Text] [Related]

  • 12. Low-calcium dialysis fluid and oral calcium carbonate in CAPD. A method of controlling hyperphosphataemia whilst minimizing aluminium exposure and hypercalcaemia.
    Hutchison AJ, Freemont AJ, Boulton HF, Gokal R.
    Nephrol Dial Transplant; 1992 Aug; 7(12):1219-25. PubMed ID: 1337163
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of calcium carbonate and low-dose vitamin D/1,25(OH)2D3 in reducing the risk of developing renal osteodystrophy in children on continuous ambulatory peritoneal dialysis.
    Jüppner H, Hoyer PF, Latta K, Winkler L, Offner G, Brodehl J.
    Pediatr Nephrol; 1990 Nov; 4(6):614-7. PubMed ID: 2088463
    [Abstract] [Full Text] [Related]

  • 14. The pathogenesis of renal osteodystrophy: role of vitamin D, aluminium, parathyroid hormone, calcium and phosphorus.
    Dunstan CR, Hills E, Norman AW, Bishop JE, Mayer E, Wong SY, Johnson JR, George CR, Collett P, Kalowski S.
    Q J Med; 1985 May; 55(217):127-44. PubMed ID: 4001311
    [Abstract] [Full Text] [Related]

  • 15. Bone disease in renal failure. Clinical and histomorphometric studies.
    Nilsson P.
    Scand J Urol Nephrol Suppl; 1984 May; 84():1-68. PubMed ID: 6393322
    [Abstract] [Full Text] [Related]

  • 16. Renal osteodystrophy in dialyzed children.
    Salusky IB, Goodman WG.
    Miner Electrolyte Metab; 1991 May; 17(4):273-80. PubMed ID: 1813790
    [Abstract] [Full Text] [Related]

  • 17. Renal osteodystrophy and aluminum bone disease in CAPD patients.
    Gokal R.
    Clin Nephrol; 1988 May; 30 Suppl 1():S64-7. PubMed ID: 3052962
    [Abstract] [Full Text] [Related]

  • 18. Renal osteodystrophy.
    Kanis JA, Cundy TF, Hamdy NA.
    Baillieres Clin Endocrinol Metab; 1988 Feb; 2(1):193-241. PubMed ID: 3044329
    [Abstract] [Full Text] [Related]

  • 19. Effects of calcifediol treatment on the progression of renal osteodystrophy during continuous ambulatory peritoneal dialysis.
    Buccianti G, Bianchi ML, Valenti G, Lorenz M, Cresseri D.
    Nephron; 1990 Feb; 56(4):353-6. PubMed ID: 2079992
    [Abstract] [Full Text] [Related]

  • 20. Renal osteodystrophy in children undergoing continuous ambulatory peritoneal dialysis.
    Hewitt IK, Stefanidis C, Reilly BJ, Kooh SW, Balfe JW.
    J Pediatr; 1983 Nov; 103(5):729-34. PubMed ID: 6631599
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.